Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19



Rating:

Share or cite this content

Citations should be made in the following way:
G. Schwarzl (Bad Reichenhall, Germany), M. Hayden (Bad Reichenhall, Germany), M. Limbach (Bad Reichenhall, Germany), S. Merkl (Bad Reichenhall, Germany), K. Jakab (Bad Reichenhall, Germany), K. Botosch (Salzburg, Austria), M. Schuler (Bochum, Germany), D. Nowak (München, Germany), K. Schultz (Bad Reichenhall, Germany). Increased rates of obstructive sleep apnea (OSA) in COVID-19-patients. 2081

Member's Comments

No comment yet.

Related content which might interest you: Predictors of hypercapnia in obstructive sleep apnoea (OSA) Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control Year: 2010 Prevalence of nocturia in obstructive sleep apnoea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 646s Year: 2006 Effect of smoking on obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 Hyperuricaemia in females with obstructive sleep apnoea (OSA) Source: Eur Respir J 2003; 22: Suppl. 45, 91s Year: 2003 Hyperuricaemia in males with obstructive sleep apnoea (OSA) Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001 Cortisol metabolism in obstructive sleep apnea (OSA) Source: Eur Respir J 2002; 20: Suppl. 38, 215s Year: 2002 NT-proBNP in obstructive sleep apnoea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 415s Year: 2006 Prevalence of stroke in obstructive sleep apnoea (OSA) patients Source: Eur Respir J 2007; 30: Suppl. 51, 331s Year: 2007 Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients Source: Eur Respir J 2004; 24: Suppl. 48, 447s Year: 2004 Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008 Obesity, obstructive sleep apnea (OSA) and asthma Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009 Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 Daytime ventilatory instability in obese patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001 Prevalence of cardiorespiratory disease increase with increasing severity of obstructive sleep apnoea (OSA) Source: Eur Respir J 2002; 20: Suppl. 38, 322s Year: 2002 Screening for obstructive sleep apnea (OSA) in acromegaly Source: Virtual Congress 2020 – Screening methods and diagnostic tools for obstructive sleep apnoea Year: 2020 Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017 Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 Prevalence and predictors of arrhythmia in patients with obstructive sleep apnea (OSA) Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011 Catecholamine secretion in obstructive sleep apnoea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 38s Year: 2005 Cardiohemodynamics parameters in patients with COPD and obstructive sleep apnea, (OSA). Source: International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea Year: 2017